Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPets at home Regulatory News (PETS)

Share Price Information for Pets at home (PETS)

Share Price is delayed by 15 minutes
Get Live Data
170.90    -3.10 (-1.78%)
Bid:
171.10
Ask:
171.40
Spread: 0.30 (0.175%)
Market Cap: £755.86m
PETS Live PriceLast checked at - London Stock Exchange

Intraday Pets at home Share Chart

Directorate Change

3 Jun 2024 07:00

RNS Number : 7499Q
Pets At Home Group Plc
03 June 2024
 

 

 

FOR IMMEDIATE RELEASE 3 June 2024

Pets at Home Group Plc: Directorate Change

Pets at Home Group plc, the UK's leading pet care business, announces a change to its Board of Directors with the appointment of a new independent Non-Executive Director.

Garret Turley will be appointed as an independent Non-Executive Director with effect from 12 July 2024.

 

On appointment to the Board, Garret will also become a member of the Nomination and Corporate Governance Committee and will chair the ESG Committee.

 

Garret is a qualified veterinarian who co-founded and built Pet Doctors, after which he transitioned into private equity at Bridges Ventures where his focus was on health and education investments. Garret then joined August Equity as a Partner, where his role focused on the healthcare, social care and education sectors through strategic investments. Garret has significant board experience and currently chairs a privately owned social care business Koala Care, is a Non- Executive Director at Dunrogan on a family office board in his native Northern Ireland and chairs Blackrose, a boutique corporate advisory house.

 

Ian Burke, Chair of Pets at Home, commented:

"On behalf of the Board, I am delighted to welcome Garret Turley to Pets at Home Group plc. Garret has excellent experience in the veterinary sector and will bring strong strategic knowledge in this area, which continues to be a key part of the group's strategy. The directors and I look forward to Garret joining in July."

This disclosure is given in accordance with Listing Rule 9.6.11.

 

 

Enquiries

Pets at Home Group Plc:

Lesley Lazenby, Company Secretary

+44 (0)161 468 6688

 

Investor Relations/Media Enquiries Pets at Home Group Plc:

Andrew Porteous, Director of Investor Relations+44 (0)161 468 6688

Natalie Cullington, Head of Media & Corporate Affairs +44 (0)161 468 6688

 

About Pets At Home

Pets at Home Group Plc is the UK's leading pet care business, providing pets and their owners with the very best advice, products and care. Pet products are available online or from over 450 pet care centres, many of which also have vet practices and grooming salons. The Group also operates a leading small animal veterinary business, with over 440 veterinary general practices located both in our pet care centres and in standalone locations. For more information visit: https://www.petsathomeplc.com/

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFFFIIRIIFIIS
Date   Source Headline
22nd Mar 20179:00 amRNSPurchase of Shares
13th Feb 20174:17 pmRNSDirector/PDMR Shareholding
19th Jan 20177:00 amRNSQ3 FY17 trading update
7th Dec 20167:21 amRNSHolding(s) in Company
30th Nov 20163:45 pmRNSDirector/PDMR Shareholding
24th Nov 20167:00 amRNSDirectorate Change
24th Nov 20167:00 amRNSHalf-year Report
3rd Nov 20168:37 amRNSAppointment of Joint Financial Adviser & Broker
20th Oct 201610:08 amRNSNOTIFICATION OF MAJOR INTEREST IN SHARESi
12th Oct 20162:22 pmRNSNotification of Transaction of PDMR
29th Sep 20167:00 amRNSHolding(s) in Company
28th Sep 20167:00 amRNSDirectorate Change
19th Sep 20162:16 pmRNSNotification of Transaction of PDMR
14th Sep 20161:42 pmRNSResult of AGM
7th Sep 20169:44 amRNSHolding(s) in Company
4th Aug 20167:30 amRNSHolding(s) in Company
4th Aug 20167:00 amRNSQ1 FY17 Trading Statement
3rd Aug 20161:39 pmRNSHolding(s) in Company
22nd Jul 20163:21 pmRNSHolding(s) in Company
18th Jul 20163:03 pmRNSNotification of Major Interest in Shares
8th Jul 20167:00 amRNSNotification of Major Interest in Shares
4th Jul 20164:42 pmRNSHolding(s) in Company
4th Jul 20169:31 amRNSHolding(s) in Company
29th Jun 201611:34 amRNSHolding(s) in Company
29th Jun 201611:33 amRNSHolding(s) in Company
22nd Jun 20169:00 amRNSNotice of AGM
17th Jun 20169:01 amRNSHolding(s) in Company
10th Jun 20162:04 pmRNSDirector/PDMR Shareholding
9th Jun 20169:33 amRNSHolding(s) in Company
9th Jun 20169:33 amRNSHolding(s) in Company
3rd Jun 20163:52 pmRNSPDMR
27th May 20163:55 pmRNSNotification of Major Interest in Shares
26th May 20167:00 amRNSFinal Results
20th May 20161:49 pmRNSChange in Director's details
29th Apr 20167:00 amRNSAcquisition
25th Apr 20164:53 pmRNSNotification of Major Interest in Shares
21st Apr 20167:00 amRNSTrading Statement
19th Apr 20163:29 pmRNSNOTIFICATION OF MAJOR INTEREST IN SHARES
11th Apr 20162:22 pmRNSUpdate to CFO Appointment
1st Apr 20161:30 pmRNSUpdate to CFO appointment
21st Mar 20167:00 amRNSDirectorate Change
4th Mar 20163:36 pmRNSConfirmation of Board Changes
1st Feb 20167:30 amRNSChange in Director's details
20th Jan 20167:00 amRNSTrading Statement
17th Dec 20157:00 amRNSDirector Declaration
16th Dec 20157:30 amRNSChange in Director's details
24th Nov 20157:00 amRNSHalf Yearly Report
20th Nov 20154:14 pmRNSNOTIFICATION OF MAJOR INTEREST IN SHARES
30th Oct 20157:00 amRNSTrading Statement
9th Oct 201512:29 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.